Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin pharmacokinetics and pharmacodynamics in type 2 diabetes with renal impairment
NL-OMON38577Active, not recruiting
- Sponsor
- University Medical Center Groningen
- Start
- Nov 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of metformin in type 2 diabetes mellitus (T2DM), sponsored by University Medical Center Groningen. Primary endpoint: Correlation between plasma metformin exposure and HbA1c. Started Nov 2013; status: active, not recruiting.
02
Drugs
metformin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NL-OMON38577.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON38577.